Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
07/2003
07/03/2003WO2003036262A3 Method and apparatus for distinguishing crohn's disease from ulcerative colitis by detecting fecal antibodies to saccharomyces cerevisiae
07/03/2003WO2003034038A3 Flow control metering system and method for controlling filtration of liquid-based specimens
07/03/2003WO2003029488A3 A method for the early detection of cancer
07/03/2003WO2003019134A3 Immunoassays using an azlactone-modified polymeric substrate
07/03/2003WO2003012396A3 Immune complexes
07/03/2003WO2002101009A3 Structural and cytoskeleton-associated proteins
07/03/2003WO2002098898A3 FLJs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE
07/03/2003WO2002090991A3 Proteins and genes for diagnosis and treatment of erbb2-related cancer
07/03/2003WO2002086495A8 Apparatus and method for determining the viability of eggs using ir-measurements
07/03/2003WO2002084299A3 Method and apparatus for detecting response to damage in plants
07/03/2003WO2002084249A3 Therapeutic and diagnostic uses of antibody specificity profiles
07/03/2003WO2002081691A3 Abcg5 and abcg8: compositions and methods of use
07/03/2003WO2002072616A3 Transfection complexes
07/03/2003WO2002070657A3 93870, a human g-protein coupled receptor and uses therefor
07/03/2003WO2002061073A3 Mutwnt fish for genetic screebibg of lipid and cholesterol metabolism
07/03/2003WO2002059604A3 Diagnosis and treatment of multiple sclerosis
07/03/2003WO2002050285A3 Histone deacetylase-related gene and protein
07/03/2003WO2002050279A3 Nucleic acid-associated proteins
07/03/2003WO2002043575A9 Zinc alpha-2-glycoprotein as indicator of cancer
07/03/2003WO2002042776A3 Compositions and methods relating to prostate specific genes and proteins
07/03/2003WO2002036761A3 Compositions and methods for the diagnosis of cancer
07/03/2003WO2002031203A9 High throughput or capillary-based screening for a bioactivity or biomolecule
07/03/2003WO2002024733A3 Human polynucleotides and polypeptides encoded thereby
07/03/2003WO2002020049A3 Eiav chimeric vaccine and diagnostic
07/03/2003WO2002014867A3 Ultra-sensitive detection systems
07/03/2003WO2002012447B1 Isolation and use of solid tumor stem cells
07/03/2003WO2002010436A3 Prognostic classification of breast cancer
07/03/2003WO2002000938A9 Methods and compositions for transcription-based nucleic acid amplification
07/03/2003WO2001077392B1 Methods for the survey and genetic analysis of populations
07/03/2003WO2000074667A3 Compositions active in telomere damage comprising a taxane and telomerase inhibitor
07/03/2003WO2000031303A3 Methods for stool sample preparation
07/03/2003US20030126630 Plant sterol reductases and uses thereof
07/03/2003US20030125887 Significant signal extracting method, recording medium, and program
07/03/2003US20030125884 Methods and systems for high throughput analysis
07/03/2003US20030125883 Information processing system using nucleotide sequence-related information
07/03/2003US20030125882 Method and apparatus for providing a bioinformatics database
07/03/2003US20030125536 Fusion proteins/antigen presenting cells for promoting expansion of lymphocytes; vaccines
07/03/2003US20030125535 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/03/2003US20030125533 Regulation of human sphingosine kinase-like protein
07/03/2003US20030125403 Comprises cellulose acetates as polymer, 1,4-dioxane, 4-hydroxymethylpentanone, and/or ethyl acetate as solvent, and n-octanol and/or 2-methyl-2,4-pentanediol as pore former; for measuring blood glucose concentration/hematocrit
07/03/2003US20030125337 Enhancing the antibacterial action of fluoroquinolones by contacting a bacterium with an indole, a urea, an aromatic amide or a quinoline
07/03/2003US20030125330 Anxiolytics and antidepressants
07/03/2003US20030125319 Administering an estrogen agonist/ antagonist while reducing the side effects associated with estrogen administration; urinary and vaginal infections; incontinence; vaginal dryness; kits for assessing vaginal health
07/03/2003US20030125315 Providing a focused approach that permits a more rapid screening of probes with potential for association with a particular binding site with a higher likelihood of success; combinatorial chemistry; screening; computer software
07/03/2003US20030125289 Noonan syndrome gene
07/03/2003US20030125286 Transcriptional silencer protein NRF
07/03/2003US20030125285 Method of examining efficacy of therapy with nucleic acid
07/03/2003US20030125284 Agents that modulate DNA-PK activity and methods of use thereof
07/03/2003US20030125265 Administering to a cancer paient a compound (emodin, genistein) having anti-estrogen receptor activity and tyrosine kinase inhibitor activity to prevent esterogen receptor positive cancer cells
07/03/2003US20030125263 Nucleic acid ligand complexes
07/03/2003US20030125262 Methods and reagents for regulation of cellular responses in biological systems
07/03/2003US20030125257 A olilgopeptide or polypeptide containing Leustatin, Chastatin or Tyrstatin
07/03/2003US20030125235 Treating a condition comprising administering a pharmaceutically effective amount of an inhibitor of the Tec family of protein tyrosine kinases (PTKs). The condition is typically associated with cytokine production, for treatment
07/03/2003US20030125234 Alteration of protein stability
07/03/2003US20030125231 Identification of agents useful in the treatment of such diseases based upon the agent's effect on reducing Pim-2 expression. Polypeptides and genetic engineering
07/03/2003US20030125230 Compositions for maintaining the integrity of the gastrointestinal tract luminal lining in a mammal, including (1) limiting epithelial cell proliferation, (2) inhibiting ulcerative lesion formation, (3) inhibiting inflammation
07/03/2003US20030124911 Modular analytical system
07/03/2003US20030124746 Light-controlled electrokinetic assembly of particles near surfaces
07/03/2003US20030124745 Measuring and detecting biological binding partners using conjugate probes; immunocytochemistry; immunoassays; chromatography; pesticide residue analysis
07/03/2003US20030124744 Methods for detecting and extracting gold
07/03/2003US20030124743 Immunoassay for detection of very low density lipoprotein and antibodies useful therefor
07/03/2003US20030124740 Binding assay device with non-absorbent carrier material
07/03/2003US20030124739 High throughput assay for visual and quantitative measurement and detection of particles in sample; immunoassays
07/03/2003US20030124738 Bar code readable diagnostic strip test
07/03/2003US20030124737 Human chorionic gonadotropin (hCG); cancer diagnosis; antitumor agents; gestational trophoblast diseases
07/03/2003US20030124735 Transferring materials onto microtiter plates (MTPs); high throughput assays
07/03/2003US20030124733 Analyzing light signals generated by a set of light scattering particles; resonance light scattering (RSL); high throughput assay
07/03/2003US20030124731 Method to ascertain whether soluble hardness is calcium or magnesium based
07/03/2003US20030124730 Fluorometric monitoring and control of soluble hardness of water used in industrial water systems
07/03/2003US20030124728 Nuclear magnetic resonance analysis of moisture, lipids and oil concentration in foods
07/03/2003US20030124717 Method of manufacturing carbon cylindrical structures and biopolymer detection device
07/03/2003US20030124715 Novel filtrate plate device and reversible-well plate device
07/03/2003US20030124704 Neuroprotectants; inhibition of axonal growth; antitumor agents
07/03/2003US20030124695 Genes encoding baeyer-villiger monooxygenases
07/03/2003US20030124678 Interleukin-2 mutants with reduced toxicity
07/03/2003US20030124677 Amino-terminally truncated MCP-2 as chemokine antagonists
07/03/2003US20030124675 Isolated CDNA encoding tumor necrosis factor binding protein II, its purification, and vectors, hosts and processes using such cDNA
07/03/2003US20030124673 Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors therefor
07/03/2003US20030124662 Secreted and transmembrane polypeptides and nucleic acids encoding the same
07/03/2003US20030124659 Multiplexing method
07/03/2003US20030124658 Molecular display on multmeric protein scaffolds derived from the e2 component of the alphaketoacid dehydrogenase
07/03/2003US20030124655 Receptor protein specifically recognizing bacterial dna
07/03/2003US20030124649 Membrane associated proteins
07/03/2003US20030124641 Method for identifying endocrine disruptors and kit for carrying out the same
07/03/2003US20030124639 Bioanalytical measuring method for determining catalases and peroxidases, as well as conjugates, substrates, activators and inhibitors thereof
07/03/2003US20030124638 Low molecular weight heparin assay, system and reagent therefor
07/03/2003US20030124637 Diagnosing organopathy; monoclonal antibodies; antiinflammatory agents
07/03/2003US20030124636 Monitoring metabolic phenotypes of bradycardial agents; immunoassays
07/03/2003US20030124635 Immunoaffinity chromatography; anticaries agents; polyclonal serums
07/03/2003US20030124633 Diagnostic methods
07/03/2003US20030124632 Diagnostic methods
07/03/2003US20030124630 Monitoring monoclonal antibody reactivity to glycosylated fungal proteins; fungicides; immunoassays
07/03/2003US20030124629 Methods of detecting a cell
07/03/2003US20030124628 Detecting modulators of membrane protein binding/signal transduction; g-protein coupled receptors; calcium channel modulators; leukocytes; antitumor/anticarcinogenic agents; antiinflammatory agents
07/03/2003US20030124627 Diagnostic and therapeutic compositions and methods related to chemokine (C motif ) XC receptor 1 (CCXCR1), a G protein-coupled receptor (GPCR)
07/03/2003US20030124626 Method of screening antiplatelet
07/03/2003US20030124624 Transmembrane proteins produced by hybridomas for distinguishing t-helper cells lines; immunoassays; diagnosing allergies; interleukins
07/03/2003US20030124623 Portable quantitative bioassays for production of concentration gradients of immobilized analytes based on surface plasmon resonance, phosphorescence, and chemiluminesence
07/03/2003US20030124622 Procedure for the determination of the activity of the protease which activates factor VII from protein solutions
07/03/2003US20030124621 Culturing/analyzing reaction of FC receptor-expressing cell line in the presence if immobilized antibody, separate, from Fab fragments; may be pretreated with cytokines or interefrons
1 ... 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 2578 ... 3937